Showing results (151-160 of 178) with videos related to
Sort By:
Pageof 18
American Journal of Hematology|July 1, 1990
Human immunodeficiency virus-1 disease progression in hemophiliacsP R Becherer, M L Smiley, T J Matthews, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 16, 2002
Use of recombinant factor IX in subjects with haemophilia B undergoing surgeryM V Ragni, K J Pasi, G C White, et al.The Biochemical Journal|October 15, 1989
The identification of sarcoplasmic reticulum terminal cisternae proteins in plateletsT H Fischer, D W Barton, K H Krause, et al.The American Journal of Medicine|September 16, 1991
Nosocomial infection rate as a function of human immunodeficiency virus type 1 status in hemophiliacsD J Weber, P R Becherer, W A Rutala, et al.American Journal of Hematology|May 1, 1988
Transmission of human immunodeficiency virus to sexual partners of hemophiliacsM L Smiley, G C White, P Becherer, et al.Journal of Thrombosis and Haemostasis : JTH|February 5, 2009
Rap1b is critical for glycoprotein VI-mediated but not ADP receptor-mediated alpha2beta1 activationZ Wang, S P Holly, M K Larson, et al.Blood|December 1, 1982
Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function testsG C White, K D Zeitler, H R Lesesne, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|April 7, 2005
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover studyC M Kessler, J C Gill, G C White, et al.Nouvelle Revue Francaise D'Hematologie|January 1, 1986
Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIIIY Sultan, G C White, A Aronstam, et al.Annals of Surgery|April 1, 1990
Wound infection rates after invasive procedures in HIV-1 seropositive versus HIV-1 seronegative hemophiliacsJ L Buehrer, D J Weber, A A Meyer, et al.Pageof 18